Palvella Therapeutics (PVLA) FCF Margin (2014 - 2026)
Palvella Therapeutics (PVLA) posted FCF Margin of -2079.25% for Q1 2024, down 1529.79 percentage points from -549.45% a year earlier and down 3654.30 percentage points from the prior quarter.
Palvella Therapeutics (PVLA) FCF Margin (2014 - 2026) Analysis & Trends
For FY2023, Palvella Therapeutics' FCF Margin came in at -32.41%, up 202.99 percentage points from FY2022.
- Annual FCF Margin shows a five-year change of -22.91 percentage points (FY2018 to FY2023).
- In prior years, Palvella Therapeutics' FCF Margin was -235.40% in FY2022 (-208.00 pp), -27.40% in FY2021 (+138.41 pp), -165.82% in FY2020 (-47.12 pp) and -118.69% in FY2019 (-109.19 pp).
- The Q1 2024 figure stands as the lowest quarterly FCF Margin in data going back to Q1 2015.
- On a year-over-year basis, FCF Margin increased in four of the last eight quarters, with an average year-over-year change of -102.45 percentage points.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2023, with a gain of 1796.10 percentage points; the weakest was Q1 2024, with a drop of 1529.79 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was 1575.06% (Q4 2023), -50.16% (Q3 2023) and -67.20% (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.65 Bn | 1,100.24 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 615.89 Bn | 534.41 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 505.03 Bn | 478.14 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 368.78 Bn | 323.16 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.66 Bn | 262.65 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 262.09 Bn | 235.78 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 236.57 Bn | 191.97 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.05 Bn | 165.25 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.60 Bn | 117.25 Bn | 10.94 Bn | 2.01% |
| 10 | Palvella Therapeutics | 1.81 Bn | 1.56 Bn | - | -651.86% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -651.86% |
| Mar 31, 2026 | -1,015.84% |
| Dec 31, 2025 | -943.46% |
| Sep 30, 2025 | -1,257.64% |
| Jun 30, 2025 | -782.90% |
| Mar 31, 2025 | -904.26% |
| Dec 31, 2024 | -1,919.22% |
| Mar 31, 2024 | -2,079.25% |
| Dec 31, 2023 | 1,575.06% |
| Sep 30, 2023 | -50.16% |
| Jun 30, 2023 | -67.20% |
| Mar 31, 2023 | -549.45% |
| Dec 31, 2022 | -221.04% |
| Sep 30, 2022 | -164.10% |
| Jun 30, 2022 | -438.26% |
| Mar 31, 2022 | -206.01% |
| Dec 31, 2021 | -133.67% |
| Sep 30, 2021 | -365.64% |
| Jun 30, 2021 | 903.41% |
| Mar 31, 2021 | -405,533.33% |
Palvella Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();